Literature DB >> 18712428

Acute stroke unit care and early neurological deterioration in ischemic stroke.

Jaume Roquer1, Ana Rodríguez-Campello, Meritxell Gomis, Jordi Jiménez-Conde, Elisa Cuadrado-Godia, Rosa Vivanco, Eva Giralt, Maria Sepúlveda, Claustre Pont-Sunyer, Gracia Cucurella, Angel Ois.   

Abstract

OBJECTIVE: To evaluate the impact that monitored acute stroke unit care may have on the risk of early neurological deterioration (END), and 90-day mortality and mortality-disability.
METHODS: Non-randomized prospective study with consecutive patients with acute ischemic stroke (AIS) admitted to a conventional care stroke unit (CCSU), from May 2003 to April 2005, or to a monitored acute stroke unit (ASU) from May 2005 to April 2006. END was defined as an increase in the NIHSS score >or= 4 points in the first 72 hours after admission.
RESULTS: END was detected in 19.6% of patients (11.2% of patients admitted to the ASU and 23.8% to the CCSU; p<0.0001). Patients admitted to the ASU received more treatment with intravenous rtPa (13.5% versus 4.2%; p<0.0001), had a shorter length of stay (9.1 [11.0] d versus 13.1 [10.4] d; p<0.0001), lower 90-day mortality (10.2% versus 17.3%; p=0.02), and lower mortality-disability at 90-days (28.4% versus 40.2%; p=0.004) than those admitted to the CCSU. Multivariable analysis showed that ASU admission was a protector for END (OR: 0.37; 95% CI: 0.23-0.62). On admission, higher NIHSS (OR: 1.06; 95% CI: 1.03-1.10), higher glycaemia (OR: 1.003; 95% CI: 1.001-1.006), and higher systolic pressure (OR: 1.01; 95% CI: 1.002-1.017) were independent predictors of END.
CONCLUSIONS: END prevention by ASU care might be a key factor contributing to better outcome and decrease of length of stay in patients admitted to monitored stroke units.

Entities:  

Mesh:

Year:  2008        PMID: 18712428     DOI: 10.1007/s00415-008-0820-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  28 in total

1.  Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial.

Authors:  L B Goldstein; G P Samsa
Journal:  Stroke       Date:  1997-02       Impact factor: 7.914

2.  Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials.

Authors:  T J DeGraba; J M Hallenbeck; K D Pettigrew; A J Dutka; B J Kelly
Journal:  Stroke       Date:  1999-06       Impact factor: 7.914

3.  Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1997-04-19

4.  Neurologic worsening during the acute phase of ischemic stroke.

Authors:  Christian Weimar; Thomas Mieck; Joachim Buchthal; Christiane E Ehrenfeld; Elisabeth Schmid; Hans-Christoph Diener
Journal:  Arch Neurol       Date:  2005-03

5.  Semi-intensive monitoring in acute stroke and long-term outcome.

Authors:  Yolanda Silva; Montserrat Puigdemont; Mar Castellanos; Joaquín Serena; Rosa M Suñer; María M García; Antoni Dávalos
Journal:  Cerebrovasc Dis       Date:  2004-11-03       Impact factor: 2.762

6.  Monitoring after the acute stage of stroke: a prospective study.

Authors:  Andrea Rocco; Marta Pasquini; Emanuella Cecconi; Gaia Sirimarco; Maria C Ricciardi; Edoardo Vicenzini; Marta Altieri; Vittorio Di Piero; Gian L Lenzi
Journal:  Stroke       Date:  2007-02-22       Impact factor: 7.914

7.  Stroke care delivery in institutions participating in the Registry of the Canadian Stroke Network.

Authors:  Moira K Kapral; Andreas Laupacis; Stephen J Phillips; Frank L Silver; Michael D Hill; Jiming Fang; Janice Richards; Jack V Tu
Journal:  Stroke       Date:  2004-05-13       Impact factor: 7.914

8.  Cerebrovascular disease in the community: results of a WHO collaborative study.

Authors:  K Aho; P Harmsen; S Hatano; J Marquardsen; V E Smirnov; T Strasser
Journal:  Bull World Health Organ       Date:  1980       Impact factor: 9.408

9.  Admitting acute ischemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomized pilot study.

Authors:  Geert Sulter; Jan Willem Elting; Marc Langedijk; Natasha M Maurits; Jacques De Keyser
Journal:  Stroke       Date:  2003-01       Impact factor: 7.914

10.  Aspirin in the prevention of progressing stroke: a randomized controlled study.

Authors:  A Rödén-Jüllig; M Britton; K Malmkvist; B Leijd
Journal:  J Intern Med       Date:  2003-12       Impact factor: 8.989

View more
  23 in total

1.  What change in the National Institutes of Health Stroke Scale should define neurologic deterioration in acute ischemic stroke?

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-06-21       Impact factor: 2.136

2.  Ischemic stroke in prediabetic patients.

Authors:  Jaume Roquer; Ana Rodríguez-Campello; Elisa Cuadrado-Godia; Eva Giralt-Steinhauer; Jordi Jiménez-Conde; Irene R Dégano; Angel Ois
Journal:  J Neurol       Date:  2014-07-15       Impact factor: 4.849

3.  Challenges enrolling patients with acute ischemic stroke into cell therapy trials.

Authors:  Farhaan S Vahidy; Susan Alderman; Sean I Savitz
Journal:  Stem Cells Dev       Date:  2012-10-15       Impact factor: 3.272

4.  [Regional and national stroke units in Germany: amended certification criteria].

Authors:  D G Nabavi; E B Ringelstein; J Faiss; C Kessler; J Röther; O Busse
Journal:  Nervenarzt       Date:  2012-08       Impact factor: 1.214

5.  Urgent decisions and a tight spot: embolic infarction of a herniated cerebellar tonsil.

Authors:  Ruth Mc Donagh; David Bradley; Joseph Augustine Harbison
Journal:  BMJ Case Rep       Date:  2016-08-03

6.  Identification of modifiable and nonmodifiable risk factors for neurologic deterioration after acute ischemic stroke.

Authors:  James E Siegler; Amelia K Boehme; Andre D Kumar; Michael A Gillette; Karen C Albright; T Mark Beasley; Sheryl Martin-Schild
Journal:  J Stroke Cerebrovasc Dis       Date:  2012-12-16       Impact factor: 2.136

7.  Sex-related differences in primary intracerebral hemorrhage.

Authors:  Jaume Roquer; Ana Rodríguez-Campello; Jordi Jiménez-Conde; Elisa Cuadrado-Godia; Eva Giralt-Steinhauer; Rosa María Vivanco Hidalgo; Carol Soriano; Angel Ois
Journal:  Neurology       Date:  2016-06-08       Impact factor: 9.910

8.  Biological age is a novel biomarker to predict stroke recurrence.

Authors:  Carol Soriano-Tárraga; Uxue Lazcano; Jordi Jiménez-Conde; Angel Ois; Elisa Cuadrado-Godia; Eva Giralt-Steinhauer; Ana Rodríguez-Campello; Alejandra Gomez-Gonzalez; Carla Avellaneda-Gómez; Rosa M Vivanco-Hidalgo; Jaume Roquer
Journal:  J Neurol       Date:  2020-08-12       Impact factor: 4.849

9.  Association between neurological deterioration and outcomes in patients with stroke.

Authors:  Peipei Liu; Shoufeng Liu; Ning Feng; Yajing Wang; Yuan Gao; Jialing Wu
Journal:  Ann Transl Med       Date:  2020-01

10.  Heart failure in acute ischemic stroke.

Authors:  Elisa Cuadrado-Godia; Angel Ois; Jaume Roquer
Journal:  Curr Cardiol Rev       Date:  2010-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.